Part II of the results of the 2018 'Benchmarking' study—analysed to highlight the capabilities and weaknesses of patient groups from 21 countries/geographic areas of the world Press release. The results of a new survey:BENCHMARKING THE PATIENT MOVEMENT, 2018Part II: country/region analysis Embargoed publication date of Part II of the 'Benchmarking' report: Thursday, 30th August 2018, 6am GMTThe 'Benchmarking the Patient Movement 2018' study finds the patient movement of 2018 to have far more impact on society than it did when the first 'Benchmarking' study was carried out in 2012. However, 2018's patient movement remains fragmented, overly competitive, and its component patient groups continue to lack confidence about their role in national healthcare systems.
The results of the 2018 'Benchmarking' study is divided into two reports, Part I and Part II. Both parts analyse patient-group capabilities (2018 results are also compared with those of the 2014 and 2012 'Benchmarking' studies). Part I was published on August 29th, 2018. Part II of the 2018 'Benchmarking' report (Part II is published today) compares the strengths and weaknesses of patient groups from the following 21 countries/regions of the world: Africa [new for 2018] (23 respondent patient groups) I Asia [new for 2018] (69) I Australasia (27) I Belgium [new for 2018] (40) I Central and South America (75) I Canada (29) I Cyprus/Greece [new for 2018] (16) I Eastern Europe (69) I France (65) I German-speaking countries [new for 2018] (134) I Germany (93) I Ireland [new for 2018] (21) I Italy (74) I Netherlands (36) I Nordic countries (40) I Portugal [new for 2018] (30) I Russia [new for 2018] (16) I Spain (100) I Switzerland [new for 2018] (25) I UK (80) I and USA (94) Both Parts of the 2018 'Benchmarking' report are available separately, or together. Why this 'Benchmarking' study? Despite the obvious importance of patient groups, no real mechanism exists to measure the patient movement's impact upon healthcare—besides the rather arbitrary measures of the numbers of patient groups, or patient groups’ own accounts of their successes or failures. In 2012, PatientView set out to fill such a void in measurement by developing a benchmarking tool to assess the impact of patient groups in their fields of activity, and their significance in healthcare systems. The 2018 iteration of the 'Benchmarking' study is the third time the exercise has been conducted (the previous studies were completed in 2012 and 2014). The 8 indicators for measuring the capability of patient groups So, how did the patient groups from the 21 countries/regions of the world perform for capability? Note to Table 1: Rankings in 2018 are out of 21 countries/regions. In the 2014 exercise, rankings were out of 12 countries/regions. And, in 2012, out of 10 countries/regions. Table 1: Overall rankings at capability for patient groups from 21 different countries/geographic areas
The 2018 'Benchmarking' study brings the analysis of patient-group capability completely up to date.
ABOUT PART II OF THIS REPORT:'Benchmarking the Patient Movement, 2018. Part II: Analysing 21 countries/regions Part II of the 'Benchmarking' report provides:
-End of press release-
|